Aberdeen Asset Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$104M Buy
831,899
+160,830
+24% +$19.2M 0.35% 55
2017
Q1
$79.7M Buy
671,069
+10,491
+2% +$1.26M 0.28% 61
2016
Q4
$76.2M Buy
660,578
+13,685
+2% +$1.52M 0.29% 61
2016
Q3
$67.6M Buy
646,893
+6,900
+1% +$720K 0.24% 63
2016
Q2
$62.3M Buy
639,993
+9,408
+1% +$889K 0.23% 67
2016
Q1
$60.6M Sell
630,585
-14,961
-2% -$1.36M 0.22% 69
2015
Q4
$59.7M Buy
645,546
+388,377
+151% +$36.6M 0.2% 70
2015
Q3
$23.9M Sell
257,169
-7,468
-3% -$710K 0.08% 142
2015
Q2
$24.6M Sell
264,637
-1,988
-0.7% -$185K 0.07% 151
2015
Q1
$25.3M Sell
266,625
-5,143
-2% -$476K 0.07% 155
2014
Q4
$24.1M Sell
271,768
-265,469
-49% -$22.5M 0.06% 159
2014
Q3
$43M Sell
537,237
-188,715
-26% -$14.2M 0.09% 127
2014
Q2
$51.5M Buy
725,952
+329,297
+83% +$23.2M 0.11% 118
2014
Q1
$29.4M Hold
396,655
0.08% 82
2013
Q4
$30.9M Buy
396,655
+153,600
+63% +$12M 0.09% 80
2013
Q3
$18M Buy
243,055
+102,200
+73% +$7.53M 0.05% 94
2013
Q2
$10.7M Buy
+140,855
New +$9.24M 0.03% 108

Other funds holding CME

Aberdeen Asset Management's CME Position: Q2 2017 in Review

Aberdeen Asset Management increased its CME Group (CME) stake by 24% in Q2 2017, buying an estimated $19.2M and bringing the position to 831,899 shares worth $104M. The position accounts for 0.35% of the portfolio, ranked #55.

Aberdeen Asset Management first reported a position in CME in Q2 2013 and has held it in 17 quarters since. 772 funds tracked by Wall St. Rank hold CME as of Q2 2017.

  • Aberdeen Asset Management held 831,899 shares of CME Group worth $104M as of Q2 2017.
  • Aberdeen Asset Management bought 160,830 CME Group shares in Q2 2017, an estimated $19.2M.
  • CME Group made up 0.35% of Aberdeen Asset Management's portfolio in Q2 2017, its #55 holding.
  • Aberdeen Asset Management first reported a position in CME Group in Q2 2013 and has held it in 17 quarters since.
  • 772 funds tracked by Wall St. Rank held CME Group as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.